Informe de análisis de tamaño, participación y tendencias del mercado mundial de bombas de insulina desechables: descripción general de la industria y pronóstico hasta 2031

Análisis del mercado de bombas de insulina desechables  

El mercado de las bombas de insulina desechables está experimentando un crecimiento significativo, impulsado por la creciente prevalencia de la diabetes y la creciente demanda de dispositivos innovadores y fáciles de usar. Con una población mundial de diabéticos que se prevé que alcance los 643 millones en 2030, la necesidad de sistemas eficaces de administración de insulina es más crítica que nunca. Los desarrollos recientes en el mercado incluyen la introducción de bombas de insulina desechables avanzadas con sistemas integrados de monitorización continua de la glucosa (MCG), que mejoran la gestión de la glucosa y proporcionan datos en tiempo real a los usuarios. Las empresas se están centrando en diseños centrados en el usuario, como modelos sin tubo y ligeros, que mejoran la comodidad y reducen la carga de la gestión de la diabetes. Además, las aprobaciones reglamentarias para nuevos sistemas de administración de insulina desechables, como la reciente autorización de la FDA de varios productos de vanguardia, están ampliando el acceso al mercado y aumentando la confianza de los consumidores. Las colaboraciones entre empresas tecnológicas y proveedores de atención médica también están acelerando la innovación, lo que lleva al desarrollo de bombas de insulina inteligentes que se conectan con aplicaciones móviles para una mejor gestión de la diabetes. A medida que la concienciación sobre la gestión de la diabetes sigue aumentando, el mercado de las bombas de insulina desechables está preparado para un crecimiento sólido, mejorando la calidad de vida de las personas con diabetes.

Tamaño del mercado de bombas de insulina desechables

El tamaño del mercado global de bombas de insulina desechables se valoró en USD 3.57 mil millones en 2023 y se proyecta que alcance los USD 6.50 mil millones para 2031, con una CAGR del 7.77% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Tendencias del mercado de bombas de insulina desechables

“ Aumento de la integración de tecnologías inteligentes”

The disposable insulin pumps market is gaining traction as patients seek convenient and cost-effective solutions for diabetes management. A prominent trend in the  market is the increasing shift towards smart technology integration, enhancing the functionality and user experience of these devices. These advanced insulin pumps now often feature wireless connectivity, allowing patients to monitor their glucose levels and manage insulin delivery through smartphone applications. For instance, devices such as Omnipod DASH have gained traction by providing a tubeless design with real-time data tracking, which improves patient adherence and ease of use. As diabetes management becomes more personalized, the demand for disposable insulin pumps with advanced features, such as automated insulin dosing and data sharing with healthcare providers, is rising. Such trend highlights the growing importance of technology in providing effective and convenient treatment options for patients with diabetes.

Report Scope and Disposable Insulin Pumps Market Segmentation  

Disposable Insulin Pumps Market Definition

Disposable insulin pumps are compact, portable devices designed to deliver precise doses of insulin to individuals with diabetes, they are designed for single-use and come pre-filled with insulin. These pumps often feature user-friendly interfaces and are equipped with technology to facilitate easy insulin administration, helping to manage blood glucose levels effectively. They may also include advanced functionalities, such as integration with continuous glucose monitoring systems, enabling real-time glucose tracking and automated insulin delivery. T Their ease of use and convenience make disposable insulin pumps a popular choice for patients looking for a straightforward way to manage their diabetes.

Disposable Insulin Pumps Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes is a significant driver for the disposable insulin pumps market, as the increasing global incidence of both type 1 and type 2 diabetes necessitates effective insulin delivery systems. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, and this number is projected to reach 783 million by 2045. This alarming trend underscores the urgent need for innovative diabetes management solutions, including disposable insulin pumps that offer convenience and precision in insulin delivery. As the population of diabetes patients continues to grow, particularly in regions such as Asia-Pacific where the prevalence is rapidly increasing, the demand for disposable insulin pumps is expected to expand significantly, creating lucrative opportunities for manufacturers and healthcare providers in this evolving market.

• Rising Global Aging Population

The global aging population significantly influences the demand for easy-to-use insulin delivery devices, as older adults are more prone to diabetes and its associated complications. According to the World Health Organization (WHO), the number of people aged 60 and older is expected to reach 2.1 billion by 2050, representing a substantial increase from 1 billion in 2019. Such demographic shift is accompanied by a higher prevalence of diabetes, with estimates suggesting that approximately 10% of older adults are living with the condition. As managing diabetes becomes increasingly complex with age, there is a growing need for user-friendly insulin delivery systems, such as disposable insulin pumps, that offer simplicity and convenience.  Consequently, the demand for such solutions is expected to rise as healthcare providers aim to enhance the quality of life for older adults living with diabetes, ultimately driving the market.

Opportunities

• Rising Technological Advancements

Technological advancements in disposable insulin pump technology are significantly enhancing patient experiences through the incorporation of smart features such as remote monitoring and automated insulin delivery systems. For instance, the Medtronic MiniMed 770G system integrates continuous glucose monitoring (CGM) with an insulin pump, allowing for automated insulin delivery adjustments based on real-time glucose readings. This closed-loop system simplifies diabetes management for patients and helps maintain optimal glucose levels, reducing the risk of hypoglycemia. Furthermore, companies that focus on developing advanced algorithms and connectivity features, such as those that enable seamless integration with mobile applications, are poised to capitalize on this trend. As technology continues to evolve, these innovations represent substantial opportunities for companies to improve diabetes management and enhance patient adherence to treatment protocols.

• Increasing Healthcare Expenditure

Increased healthcare expenditure, especially in developed regions, plays a crucial role in fostering the adoption of advanced medical devices, such as disposable insulin pumps. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is projected to grow at an average rate of 5.4% annually, reaching approximately USD 6 trillion by 2027. Such surge in investment enhances access to innovative diabetes management solutions, as healthcare systems prioritize funding for technologies that improve patient outcomes and streamline care. For instance, initiatives that reimburse patients for the use of modern insulin delivery systems, including disposable insulin pumps, are becoming more common, allowing for broader access among diabetic patients. As a result, the growth in healthcare expenditure is directly correlated with improved access to effective diabetes care solutions, ultimately creating opportunities in the market.

Restraints/Challenges

• High Equipment Costs

The high cost of disposable insulin pumps serves as a significant market challenge, particularly for patients in regions with limited insurance coverage or considerable out-of-pocket expenses. As disposable insulin pumps can be prohibitively expensive, they become inaccessible to individuals with lower incomes or inadequate insurance plans. Consequently, many patients may opt for less expensive alternatives, such as traditional insulin syringes or pens, which, although effective, fail to provide the same level of convenience and efficiency in diabetes management. Such financial burden hinders the adoption of advanced insulin delivery systems and contributes to poorer health outcomes, as individuals unable to afford these technologies may struggle to maintain optimal blood glucose levels, thereby increasing their risk of diabetes-related complications.

• Limited Equipment Awareness

Limited awareness of disposable insulin pumps presents a notable challenge in their adoption, as both patients and healthcare providers may not fully understand the availability and benefits of these innovative devices. Despite their advantages, such as ease of use and improved diabetes management, many individuals continue to rely on traditional methods due to a lack of information. Such gap in awareness can result in missed opportunities for better glycemic control and overall health outcomes, as patients may struggle with the more cumbersome traditional methods. In addition, healthcare providers in these areas may not prioritize educating their patients about the latest technologies, further hampering the overall market expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Disposable Insulin Pumps Market Scope

The market is segmented on the basis of type, products, accesories and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Patch pumps
• Tethered pumps

Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• others

Accessories

• Insulin Eeservoir or Cartridges
• Insulin Set Insertion Devices
• Battery

End-Users

• Hospitals and Clinics
• Home Care
• Laboratories

Disposable Insulin Pumps Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, products, accesories and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America stands out as the leading region in the market, primarily due to its well-established healthcare and medical facilities that ensure comprehensive patient care. The presence of major medical manufacturers and key players further enhances the region's dominance, facilitating innovation and access to advanced medical technologies. In addition, high healthcare expenditure in North America supports ongoing research and development, driving growth in the medical market.

Asia-Pacific region is projected to experience substantial growth during the forecast period from 2024 to 2031, largely driven by the rising prevalence of diabetes. As lifestyle changes and an aging population contribute to increasing diabetes rates, there is a growing demand for effective management and treatment solutions. This surge in demand is prompting healthcare providers and stakeholders in the region to invest in innovative diabetes care technologies and services, further fueling market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Disposable Insulin Pumps Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Disposable Insulin Pumps Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• Insulet Corporation (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• SOOIL Developments Co., Ltd (South Korea)
• Tandem Diabetes Care, Inc. (U.S.)
• SHINMYUNG MEDIYES CO., LTD. (South Korea)
• Debiotech SA (Switzerland)
• TOP Corporation (Japan)
• Kingfa Sci.&Tech. Co., Ltd (China)
• Sphere Fluidics (U.K.)
• Medsolve (UK) Limited (U.K.)
• Sanofi (France)
• Abbott (U.S.)
• BD (U.S.)

Latest Developments in Disposable Insulin Pumps Market

• En septiembre de 2024, Embecta Corp., líder mundial en el cuidado de la diabetes con un siglo de trayectoria en la administración de insulina, anunció que recibió la autorización 510(k) de la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) para su innovador sistema de administración de insulina desechable. Diseñado para adultos que controlan la diabetes, incluidos los tipos 1 (DT1) y 2 (DT2), este sistema cuenta con un diseño de bomba de parche sin tubo equipado con un depósito de insulina de 300 unidades, desarrollado en base a los conocimientos de personas con DT2 y sus proveedores de atención médica.
• En marzo de 2024, la FDA aprobó el sistema de administración automática de insulina (AID) twiist, lo que lo convierte en la primera bomba de insulina que se integra con Tidepool Loop. Aprobado para personas con diabetes tipo 1 de 6 años o más, el sistema AID twiist, junto con Tidepool Loop, proporciona capacidades de microdosificación precisas, permite a los usuarios establecer un objetivo tan bajo como 87 mg/dl y ofrece opciones de administración de bolos en función de varios tipos de alimentos.
• En enero de 2024, Medtronic plc, líder mundial en tecnología sanitaria, anunció que recibió la aprobación de la marca CE (Conformité Européenne) para el sistema MiniMed™ 780G, que incluye Simplera Sync, un monitor continuo de glucosa (MCG) desechable y todo en uno que elimina la necesidad de punciones en el dedo o de cinta adhesiva. Simplera Sync ofrece una experiencia de usuario mejorada con un proceso de inserción sencillo de dos pasos y tiene la mitad del tamaño de los sensores Medtronic anteriores.
• En diciembre de 2023, Medtronic canceló sus planes de adquirir EOFlow, una empresa que fabrica una bomba de parche de insulina que actualmente está involucrada en una disputa de patentes con Insulet. Medtronic citó "múltiples incumplimientos" de los acuerdos entre las dos empresas como motivo de la decisión. Este año, EOFlow se ha enfrentado a un litigio de patentes en curso con Insulet
• En mayo de 2023, Embecta se asoció con Tidepool para colaborar en el desarrollo de una innovadora bomba de insulina diseñada para mejorar el control de la diabetes. Esta alianza estratégica tiene como objetivo integrar tecnología avanzada y funciones fáciles de usar en el dispositivo, mejorando los resultados de los pacientes. Además, Embecta ha elevado sus perspectivas de crecimiento para el segundo trimestre, lo que refleja la confianza en su cartera de productos y la demanda del mercado.

SKU-63894